Board Member
Idexx Laboratories Inc /De (IDXX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Michael (Mike) Erickson is recorded as CEO and Board Member at Idexx Laboratories Inc /De (IDXX). Idexx Laboratories Inc /De reported in an 8-K filed January 13, 2026 that Michael (Mike) Erickson was appointed Board of Directors, effective May 12, 2026. Idexx Laboratories Inc /De reported in an 8-K filed January 13, 2026 that Michael (Mike) Erickson was appointed President and Chief Executive Officer, effective May 12, 2026. Michael (Mike) Erickson has spoken on 1 earnings call and 1 other investor event across 1 company, most recently for Idexx Laboratories Inc /De on September 14, 2026.
“Dr. Erickson will also join the Board, effective upon his assumption of the role of President and CEO.”
“IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced the promotion of Michael (Mike) Erickson, PhD, to President and Chief Executive Officer, effective May 12, 2026, at which time Jonathan (Jay) Mazelsky, President and CEO, will transition to the role of Executive Chair of IDEXX's Board of Directors (the "Board").”
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
2026-05-12–present
2026-05-12–present
Recorded roles and call appearances connecting this person to public companies.
CEO, Board Member
2026-05-12–present
Other people whose current roles at this company are on record from its filings.
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
